Clinical Study
Management of Hypertension in the Elderly Patient at Abidjan Cardiology Institute (Ivory Coast)
Table 2
Type of drugs used.
| Type of drug | % |
| One drug (33.1%) | | Calcium antagonists | 36.3 | RAS blockers | 32 | Diuretics | 16 | β-blockers | 10.7 | CAS | 5 |
| Two drugs (53.8%) | | RAS blockers + Diuretics | 69.8 | β-blockers + Diuretics | 8.5 | β-blockers + Calcium antagonists | 7.4 | Diuretics + Calcium antagonist | 5.5 | RAS Blockers + Calcium antagonists | 3.5 | RAS Blockers + β-blockers | 3.5 | CAS + (diuretics or RAS blockers or calcium antagonist or β-blockers) | 1.8 |
| Three drugs (11%) | | RAS blockers + Diuretics + Calcium antagonists | 51.7 | RAS blockers + Diuretics + β-blockers | 18.4 | Diuretics + β-blockers + Calcium antagonists | 17.2 | RAS blockers + β-blockers + Calcium antagonists | 2.3 | Other using CAS | 10.4 |
| Four drugs (2.2%) | | RAS blockers + Diuretics + Calcium antagonists + β-blockers | 58.8 | RAS blockers + Diuretics + Calcium antagonists+ CAS | 35.3 | RAS blockers + Diuretics + β-blockers+ CAS | 5.9 |
|
|
RAS blockers: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, CAS: Centrally acting sympatholytics.
|